thyroid diseases
Showing NaN - NaN of 3
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 16, 2021
Graves Ophthalmopathy, Graves Disease, Eye Diseases Trial in Guangzhou (Doxycycline)
Completed
- Graves Ophthalmopathy
- +8 more
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Dec 7, 2013